Iterum Therapeutics Plc

NASDAQ:ITRM   3:59:57 PM EDT
0.52
-0.03 (-5.35%)
Products

Iterum Therapeutics Provides Update From FDA Type A Meeting Regarding Oral Sulopenem

Published: 09/28/2021 12:22 GMT
Iterum Therapeutics Plc (ITRM) - Iterum Therapeutics Provides Update From FDA Type a Meeting Regarding Oral Sulopenem.
Iterum Therapeutics Provides Update From FDA Type a Meeting Regarding Oral Sulopenem.
Iterum Therapeutics Plc - Notes That Cash, Cash Equivalents and Short-term Investments Were $91.5 Million at End of Q2 of 2021.
Iterum Therapeutics Plc - Believes That It is Well Positioned Financially to Fund Its Operations Into Second Half of 2023.
Iterum Therapeutics - Currently Evaluating Optimal Design for an Additional Phase 3 Uuti Study to Be Conducted Prior to Potential Resubmission of NDA.